Cipla - Quaterly Results

10 May 2022 Evaluate
The company witnessed a 11.44% growth in the revenue at Rs. 29466.10 millions for the quarter ended March 2022 as compared to Rs. 26442.00 millions during the year-ago period.A humble growth in net profit of 13.50% reported in the quarter ended March 2022 to Rs. 4763.00  millions from Rs. 4196.60 millions.Operating profit for the quarter ended March 2022 rose to 7039.60 millions as compared to 6875.80 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 29466.10 26442.00 11.44 130917.90 113027.10 15.83 130917.90 113027.10 15.83
Other Income 3163.10 493.30 541.21 6667.00 2302.80 189.52 6667.00 2302.80 189.52
PBIDT 7039.60 6875.80 2.38 40331.70 32976.90 22.30 40331.70 32976.90 22.30
Interest 57.80 88.40 -34.62 269.30 450.70 -40.25 269.30 450.70 -40.25
PBDT 6981.80 6787.40 2.86 40062.40 32526.20 23.17 40062.40 32526.20 23.17
Depreciation 1168.20 1177.50 -0.79 4600.10 4686.20 -1.84 4600.10 4686.20 -1.84
PBT 5813.60 5609.90 3.63 35462.30 27840.00 27.38 35462.30 27840.00 27.38
TAX 1050.60 1413.30 -25.66 8568.40 7393.50 15.89 8568.40 7393.50 15.89
Deferred Tax -35.00 92.80 -137.72 -304.00 -169.20 79.67 -304.00 -169.20 79.67
PAT 4763.00 4196.60 13.50 26893.90 20446.50 31.53 26893.90 20446.50 31.53
Equity 1613.60 1612.90 0.04 1613.60 1612.90 0.04 1613.60 1612.90 0.04
PBIDTM(%) 23.89 26.00 -8.13 30.81 29.18 5.59 30.81 29.18 5.59

Cipla Share Price

1491.40 -3.00 (-0.20%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 901.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×